Detalhe da pesquisa
1.
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
BMC Cancer
; 21(1): 904, 2021 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34364385
2.
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Oncologist
; 21(2): 196-204, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26614710
3.
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Gastroenterology
; 149(3): 604-13.e20, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980754
4.
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.
J Urol
; 195(3): 612-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403586
5.
Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
BMC Cancer
; 21(1): 1023, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525968
6.
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Cancer
; 121(1): 25-33, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186627
7.
Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Oncology
; 88(4): 226-33, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25503195
8.
Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
Cancer
; 120(7): 963-7, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415441
9.
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.
Cancer
; 118(11): 2787-95, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22614657
10.
Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.
Oncologist
; 17(3): 296-302, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382460
11.
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Clin Cancer Res
; 26(18): 4795-4804, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32636319
12.
Cost effectiveness analysis of genetic testing for breast and ovarian cancer susceptibility genes: BRCA1 and BRCA2.
Breast J
; 20(3): 325-6, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708220
13.
Assessment of Proteomic Measures Across Serious Psychiatric Illness.
Clin Schizophr Relat Psychoses
; 11(2): 103-112, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742394
14.
Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry.
Curr Med Res Opin
; 30(6): 1025-31, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576172
15.
Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.
Clin Colorectal Cancer
; 10(3): 203-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21855044